-
-
-
-
-
-
-
FDA: approves Pfizer's palbociclib (ibrance) with trastuzumab for HR-positive, her2-positive metastatic breast cancer
-
-
-
-
-
-
-
Arvinas and Pfizer complete Rigel license deal for vepdegestrant
-
-
-
-
-
-
-
Morgan Stanley: China healthcare sector dips 1.3% amid licensing scrutiny
-
-
-
-
-
-
-
MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
-
-
-
-
-
-
-
Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
-
-
-
-
-
-
-
Barclays: 'We think dropping the question of '441 validity from the case is a major development'
-
439,248 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

